TEAS RF New Application

RADIUS

Radius Health, Inc.

Trademark/Service Mark Application, Principal Register

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)

Trademark/Service Mark Application, Principal Register

Serial Number: 87796289
Filing Date: 02/13/2018

The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 87796289
MARK INFORMATION
*MARK RADIUS
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT RADIUS
MARK STATEMENT The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK Radius Health, Inc.
*STREET 950 Winter Street
*CITY Waltham
*STATE
(Required for U.S. applicants)
Massachusetts
*COUNTRY United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
02451
LEGAL ENTITY INFORMATION
TYPE corporation
STATE/COUNTRY OF INCORPORATION Delaware
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS 005 
*IDENTIFICATION Pharmaceutical preparations for use in the treatment of bone diseases;
FILING BASIS SECTION 1(a)
       FIRST USE ANYWHERE DATE At least as early as 07/30/2009
       FIRST USE IN COMMERCE DATE At least as early as 07/30/2009
       SPECIMEN FILE NAME(S) \\TICRS\EXPORT17\IMAGEOUT 17\877\962\87796289\xml1\ RFA0003.JPG
       SPECIMEN DESCRIPTION photo of the box in which the pharmaceutical products are provided in
INTERNATIONAL CLASS 005 
*IDENTIFICATION Pharmaceutical preparations for use in the treatment of connective tissue diseases, inflammatory diseases, blood diseases and hormonal disorders; Pharmaceutical preparations for use in oncology; Pharmaceutical preparations for use in the treatment of wasting and other muscle, fat and tissue loss caused by medical disorders or aging; Pharmaceutical preparations for use in hormone therapy; Pharmaceutical preparations for use in the treatment of cardiovascular diseases, central and peripheral nervous system diseases, gynecological diseases, rheumatic diseases, urological diseases, gastroenterological diseases, infectious diseases, dermatological diseases, autoimmune diseases, blood diseases, genital diseases, endocrine diseases, intestinal diseases, internal medicine diseases; Pharmaceutical preparations for use in the treatment of alopecia; Pharmaceutical preparations for use in the treatment of cognitive disorders and mood disorders; Pharmaceutical preparations for use in the treatment of diabetes and insulin-related disorders and conditions; Pharmaceutical preparations to treat wounds and trauma
FILING BASIS SECTION 1(b)
ADDITIONAL STATEMENTS SECTION
ACTIVE PRIOR REGISTRATION(S) The applicant claims ownership of active prior U.S. Registration Number(s) 3687535.
ATTORNEY INFORMATION
NAME Patchen M. Haggerty
ATTORNEY DOCKET NUMBER 113401-4000
FIRM NAME Perkins Coie LLP
STREET 1201 Third Avenue, Suite 4900
CITY Seattle
STATE Washington
COUNTRY United States
ZIP/POSTAL CODE 98101
PHONE 206-359-8000
FAX 206-359-9000
EMAIL ADDRESS pctrademarks@perkinscoie.com
AUTHORIZED TO COMMUNICATE VIA EMAIL Yes
OTHER APPOINTED ATTORNEY Lindsay B. Allen, Lydia Z. Ansari, Craig A. Beaker, Stefan B. Blum, Ai-Tang I. Chang, Colleen M. Ganin, Alexander J.A. Garcia, Daniel J. Glenn, Mark S. Goodrich, Lynne E. Graybeal, John P. Halski, Thomas L. Holt, Jason S. Howell, Lisa K. Koenig, Elizabeth A. Kristoferson, Kirstin E. Larson, Winfield B. Martin, Alicia A. Matusheski, Lisa T. Oratz, Daya S. Patibandla, Seth H. Reagan, Heidi L. Sachs, Grace Han Stanton, James L. Vana and Robert G. Woolston
CORRESPONDENCE INFORMATION
NAME Patchen M. Haggerty
FIRM NAME Perkins Coie LLP
STREET 1201 Third Avenue, Suite 4900
CITY Seattle
STATE Washington
COUNTRY United States
ZIP/POSTAL CODE 98101
PHONE 206-359-8000
FAX 206-359-9000
*EMAIL ADDRESS pctrademarks@perkinscoie.com
*AUTHORIZED TO COMMUNICATE VIA EMAIL Yes
FEE INFORMATION
APPLICATION FILING OPTION TEAS RF
NUMBER OF CLASSES 1
APPLICATION FOR REGISTRATION PER CLASS 275
*TOTAL FEE DUE 275
*TOTAL FEE PAID 275
SIGNATURE INFORMATION
SIGNATURE /Brent Hatzis-Schoch/
SIGNATORY'S NAME Brent Hatzis-Schoch
SIGNATORY'S POSITION General Counsel
SIGNATORY'S PHONE NUMBER 6175514004
DATE SIGNED 02/13/2018



Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)


Trademark/Service Mark Application, Principal Register

Serial Number: 87796289
Filing Date: 02/13/2018

To the Commissioner for Trademarks:

MARK: RADIUS (Standard Characters, see mark)
The literal element of the mark consists of RADIUS.
The mark consists of standard characters, without claim to any particular font style, size, or color.

The applicant, Radius Health, Inc., a corporation of Delaware, having an address of
      950 Winter Street
      Waltham, Massachusetts 02451
      United States

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

       International Class 005:  Pharmaceutical preparations for use in the treatment of bone diseases;

In International Class 005, the mark was first used by the applicant or the applicant's related company or licensee or predecessor in interest at least as early as 07/30/2009, and first used in commerce at least as early as 07/30/2009, and is now in use in such commerce. The applicant is submitting one(or more) specimen(s) showing the mark as used in commerce on or in connection with any item in the class of listed goods/services, consisting of a(n) photo of the box in which the pharmaceutical products are provided in.
Specimen File1

       International Class 005:  Pharmaceutical preparations for use in the treatment of connective tissue diseases, inflammatory diseases, blood diseases and hormonal disorders; Pharmaceutical preparations for use in oncology; Pharmaceutical preparations for use in the treatment of wasting and other muscle, fat and tissue loss caused by medical disorders or aging; Pharmaceutical preparations for use in hormone therapy; Pharmaceutical preparations for use in the treatment of cardiovascular diseases, central and peripheral nervous system diseases, gynecological diseases, rheumatic diseases, urological diseases, gastroenterological diseases, infectious diseases, dermatological diseases, autoimmune diseases, blood diseases, genital diseases, endocrine diseases, intestinal diseases, internal medicine diseases; Pharmaceutical preparations for use in the treatment of alopecia; Pharmaceutical preparations for use in the treatment of cognitive disorders and mood disorders; Pharmaceutical preparations for use in the treatment of diabetes and insulin-related disorders and conditions; Pharmaceutical preparations to treat wounds and trauma
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.


Claim of Active Prior Registration(s)
The applicant claims ownership of active prior U.S. Registration Number(s) 3687535.

The applicant's current Attorney Information:
      Patchen M. Haggerty and Lindsay B. Allen, Lydia Z. Ansari, Craig A. Beaker, Stefan B. Blum, Ai-Tang I. Chang, Colleen M. Ganin, Alexander J.A. Garcia, Daniel J. Glenn, Mark S. Goodrich, Lynne E. Graybeal, John P. Halski, Thomas L. Holt, Jason S. Howell, Lisa K. Koenig, Elizabeth A. Kristoferson, Kirstin E. Larson, Winfield B. Martin, Alicia A. Matusheski, Lisa T. Oratz, Daya S. Patibandla, Seth H. Reagan, Heidi L. Sachs, Grace Han Stanton, James L. Vana and Robert G. Woolston of Perkins Coie LLP      1201 Third Avenue, Suite 4900
      Seattle, Washington 98101
      United States
      206-359-8000(phone)
      206-359-9000(fax)
      pctrademarks@perkinscoie.com (authorized)
The attorney docket/reference number is 113401-4000.

The applicant's current Correspondence Information:
      Patchen M. Haggerty
      Perkins Coie LLP
      1201 Third Avenue, Suite 4900
      Seattle, Washington 98101
      206-359-8000(phone)
      206-359-9000(fax)
      pctrademarks@perkinscoie.com (authorized)
E-mail Authorization: I authorize the USPTO to send e-mail correspondence concerning the application to the applicant, the applicant's attorney, or the applicant's domestic representative at the e-mail address provided in this application. I understand that a valid e-mail address must be maintained and that the applicant or the applicant's attorney must file the relevant subsequent application-related submissions via the Trademark Electronic Application System (TEAS). Failure to do so will result in the loss of TEAS Reduced Fee status and a requirement to submit an additional processing fee of $125 per international class of goods/services.

A fee payment in the amount of $275 has been submitted with the application, representing payment for 1 class(es).

Declaration

Declaration Signature

Signature: /Brent Hatzis-Schoch/   Date: 02/13/2018
Signatory's Name: Brent Hatzis-Schoch
Signatory's Position: General Counsel
Payment Sale Number: 87796289
Payment Accounting Date: 02/14/2018

Serial Number: 87796289
Internet Transmission Date: Tue Feb 13 16:58:08 EST 2018
TEAS Stamp: USPTO/BAS-XXX.XX.XXX.XXX-201802131658080
84597-87796289-51095e3c7af336f73dccd5e69
4a1bcd34ec815d83867bb3aca659034ef619edda
-CC-3639-20180212174510139174

TEAS RF New Application [image/jpeg]

TEAS RF New Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed